APA (7th ed.) Citation

Palma, D. A., Olson, R., Harrow, S., Correa, R. J. M., Schneiders, F., Haasbeek, C. J. A., . . . Senan, S. (2019). Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): Study protocol for a randomized phase III trial. BMC cancer, 19(1), 816-15. https://doi.org/10.1186/s12885-019-5977-6

Chicago Style (17th ed.) Citation

Palma, David A., et al. "Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4–10 Oligometastatic Tumors (SABR-COMET-10): Study Protocol for a Randomized Phase III Trial." BMC Cancer 19, no. 1 (2019): 816-15. https://doi.org/10.1186/s12885-019-5977-6.

MLA (9th ed.) Citation

Palma, David A., et al. "Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4–10 Oligometastatic Tumors (SABR-COMET-10): Study Protocol for a Randomized Phase III Trial." BMC Cancer, vol. 19, no. 1, 2019, pp. 816-15, https://doi.org/10.1186/s12885-019-5977-6.